Structures by: Statsyuk V. E.
Total: 6
6-(4-Chlorophenyl)-3-methylimidazo[2,1-<i>b</i>]thiazole
C12H9ClN2S
Acta Crystallographica Section E (2013) 69, 11 o1701
a=7.0624(5)Å b=7.7132(5)Å c=10.3460(7)Å
α=93.3530(10)° β=90.1070(10)° γ=98.8320(10)°
2-Bromo-4-phenyl-1,3-thiazole
C9H6BrNS
Acta Crystallographica Section E (2014) 70, 2 o139
a=5.8934(3)Å b=10.6591(6)Å c=13.8697(7)Å
α=90.00° β=90.8120(10)° γ=90.00°
7-Nitro-2-phenylimidazo[2,1-<i>b</i>][1,3]benzothiazole
C15H9N3O2S
Acta Crystallographica Section E (2014) 70, 2 o143-o144
a=6.8068(3)Å b=21.0244(9)Å c=9.0699(4)Å
α=90.00° β=105.0770(10)° γ=90.00°
3-Bromo-7-methoxy-2-phenylimidazo[2,1-<i>b</i>][1,3]benzothiazole
C16H11BrN2OS
Acta Crystallographica Section E (2013) 69, 4 o531
a=3.8346(4)Å b=9.4848(11)Å c=37.236(4)Å
α=90.00° β=91.810(2)° γ=90.00°
(<i>E</i>)-1,5-Diphenylpent-2-en-4-yn-1-one
C17H12O
Acta Crystallographica Section E (2013) 69, 6 o911
a=5.4696(4)Å b=13.7164(10)Å c=16.3117(11)Å
α=90.00° β=90.00° γ=90.00°
3-Bromo-2-[4-(methylsulfanyl)phenyl]-5,6,7,8-tetrahydro-1,3-benzothiazolo[3,2-<i>a</i>]imidazole
C16H15BrN2S2
Acta Crystallographica Section E (2014) 70, 5 o596-o597
a=7.3132(3)Å b=7.5663(3)Å c=14.4543(7)Å
α=95.0330(10)° β=97.1880(10)° γ=101.9380(10)°